DygloFit® is one of five ingredients in Ozenica's Trimfexa® blend. See the full blend and the other four ingredients by clicking below.
Support your body's own satiety hormone — naturally.
DygloFit®: Natural GLP-1 Support
DygloFit® is a patented extract derived from Dichrostachys glomerata, a plant native to West Africa studied in modern clinical research for its ability to support the body's own GLP-1 hormone production and inhibit DPP-4 — the enzyme responsible for breaking GLP-1 down. It is one of a small number of natural, patented ingredients with published human clinical research specifically on GLP-1 signaling, and it is the hero ingredient in Ozenica's Trimfexa® blend.
GLP-1 (glucagon-like peptide-1) is a hormone your gut produces naturally after you eat. It sends a signal to your brain that you are full, slows the rate at which food leaves your stomach, and helps regulate blood sugar by supporting insulin release. Higher GLP-1 activity means stronger, longer-lasting feelings of satiety after meals.
Prescription GLP-1 medications introduce a synthetic version of this hormone at pharmaceutical doses. DygloFit® works differently — it supports your body's ability to produce and preserve more of its own natural GLP-1, without synthetic hormones or injections.
DPP-4 (dipeptidyl peptidase-4) is an enzyme that breaks down GLP-1 in your bloodstream, typically within minutes of it being released. The faster GLP-1 is broken down, the shorter your satiety window after eating. DygloFit® has been studied for its ability to slow DPP-4 activity — meaning the GLP-1 your body naturally produces stays active longer, extending the fullness signal without adding any synthetic hormone.
DygloFit® in Ozenica®
Specification
Ingredient form
Patented Dichrostachys glomerata extract (DygloFit®)
Dose per 2-capsule daily serving
400mg
Mechanism
Supports natural GLP-1 production; inhibits DPP-4 enzyme activity
Research basis
Published human clinical studies on GLP-1 and DPP-4 markers
Stimulant-free
Yes — no caffeine, no synephrine
Patent status
Patented ingredient — not a generic commodity extract
Frequently Asked Questions
-
DygloFit® is a patented Dichrostachys glomerata extract that supports the body's natural GLP-1 production while inhibiting DPP-4, the enzyme that breaks GLP-1 down. By raising GLP-1 and slowing its breakdown, it helps keep satiety signals active longer, which supports appetite control and a feeling of fullness. In human clinical research, it has been studied for these effects on GLP-1-related markers and metabolic measures.
-
Each 2-capsule serving of Ozenica contains 400mg of DygloFit®. The dose is printed on the label — there are no hidden or undisclosed amounts.
-
No. DygloFit® is a natural plant extract, not a pharmaceutical drug. It supports the body's own GLP-1 production rather than replacing it with a synthetic compound. It does not require a prescription and is not FDA-approved as a drug.
-
Yes. DygloFit® has been studied in human clinical trials for its effects on GLP-1-related markers and DPP-4 inhibition. It is a patented ingredient, meaning it has met the threshold of novelty and specificity required for patent protection.